This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Cytokinetics, Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Kevin Lau: Innovator in Cardiac Research
Introduction
Kevin Lau is a prominent inventor based in San Mateo, CA (US). He has made significant contributions to the field of cardiac research, particularly through his innovative patents. With a total of 3 patents to his name, Lau is recognized for his work in developing cardiac sarcomere inhibitors.
Latest Patents
Lau's latest patents focus on cardiac sarcomere inhibitors. These patents provide compounds of Formula (I) or a pharmaceutically acceptable salt thereof, wherein R, R, R, R, R, and R are defined within the documentation. Additionally, the patents include a pharmaceutically acceptable composition comprising a compound of Formula (I) and methods for using these compounds effectively.
Career Highlights
Kevin Lau is currently associated with Cytokinetics, Inc., where he continues to advance his research in cardiac health. His work is pivotal in developing therapies that could potentially improve heart function and patient outcomes.
Collaborations
Lau collaborates with notable colleagues, including Chihyuan Chuang and Bradley Paul Morgan, who contribute to his research endeavors and innovations.
Conclusion
Kevin Lau's contributions to cardiac research through his patents and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in cardiac therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile